Literature DB >> 630533

Computed tomographic scanning in patients with lymphoma.

S E Jones, D A Tobias, R S Waldman.   

Abstract

Computed tomography (CT) of the chest and abdomen was performed in 40 patients with lymphoma and the results compared to conventional diagnostic techniques. Overall 34 (85%) of 40 CT scans correctly reflected the presence or absence of lymphoma. Close agreement between the findings of lymphography and CT was noted in 26 of 27 cases. CT has particular utility for assessment of lymphomatous involvement of mesenteric lymph nodes, high retroperitoneal lymph nodes, and extranodal abdominal sites other than the spleen or liver (e.g., pancreas, kidney). Abdominal CT is a useful noninvasive diagnostic technique for the initial staging and subsequent evaluation of selected patients with lymphoma.

Entities:  

Mesh:

Year:  1978        PMID: 630533     DOI: 10.1002/1097-0142(197802)41:2<480::aid-cncr2820410215>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

Review 2.  Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes.

Authors:  G C Dooms; H Hricak
Journal:  West J Med       Date:  1986-01

3.  Management of childhood lymphomas - Hodgkin's disease and non-Hodgkin's lymphomas.

Authors:  C C Patel
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

4.  Computed tomography of abdomen in staging and clinical management of lymphoma.

Authors:  J J Best; G Blackledge; W S Forbes; I D Todd; B Eddleston; D Crowther; I Isherwood
Journal:  Br Med J       Date:  1978-12-16

5.  Role of computed tomography in staging and management of gastrointestinal lymphoma.

Authors:  G Blackledge; J K Best; D Crowther
Journal:  J R Soc Med       Date:  1979-11       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.